At treatment end , HbA1c values and the proportion of participants with HbA1c < 7.0 % ( < 53mmol/mol ) were not significantly different for glargine [ 7.1 % ( 54mmol/mol ) and 50.3 % ] versus NPH [ 7.2 % ( 55mmol/mol ) and 44.3 % ] .